跳至主要内容
临床试验/IRCT20190427043389N3
IRCT20190427043389N3招募中未知

Evaluation of the therapeutic effects of livergol (silymarin) on the neuropathy caused by chemotherapy drugs (cisplatin, oxaliplatin and paclitaxel) in patients admitted to Education & Treatment Center of Valiasr.

Zanjan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 75 years(—)
性别
All

入选标准

  • Age range 35-75 years
  • Patients with cancers receiving oxaliplatin, cisplatin or paclitaxel-based chemotherapy regimens
  • Patients with concussions admitted to Valiasr educational center or referred to Valiasr Oncology Clinic

排除标准

  • Liverpool contraindication
  • The presence of peripheral peripheral neuropathy continues to be the treatment that needs to be changed with chemotherapy regimens
  • Other underlying etiologies of neuropathy

研究者

相似试验

Evaluation of the therapeutic effects of livergol... | 临床试验